NO142713C - Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6,7-benzomorfan-derivater - Google Patents

Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6,7-benzomorfan-derivater

Info

Publication number
NO142713C
NO142713C NO741126A NO741126A NO142713C NO 142713 C NO142713 C NO 142713C NO 741126 A NO741126 A NO 741126A NO 741126 A NO741126 A NO 741126A NO 142713 C NO142713 C NO 142713C
Authority
NO
Norway
Prior art keywords
preparation
new therapeutic
therapeutic active
analogy procedure
benzomorphan derivatives
Prior art date
Application number
NO741126A
Other languages
English (en)
Other versions
NO142713B (no
NO741126L (no
Inventor
Kenji Kobayashi
Toshitsugu Fukumaru
Hiroyuki Mizote
Shigeho Inabla
Hisao Yamamoto
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of NO741126L publication Critical patent/NO741126L/no
Publication of NO142713B publication Critical patent/NO142713B/no
Publication of NO142713C publication Critical patent/NO142713C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO741126A 1973-03-31 1974-03-29 Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6,7-benzomorfan-derivater NO142713C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP48037333A JPS5817190B2 (ja) 1973-03-31 1973-03-31 シンキナ 4,5− ジアルキルベンゾモルフアンユウドウタイノセイホウ

Publications (3)

Publication Number Publication Date
NO741126L NO741126L (no) 1974-10-01
NO142713B NO142713B (no) 1980-06-23
NO142713C true NO142713C (no) 1980-10-01

Family

ID=12494691

Family Applications (1)

Application Number Title Priority Date Filing Date
NO741126A NO142713C (no) 1973-03-31 1974-03-29 Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6,7-benzomorfan-derivater

Country Status (19)

Country Link
US (1) US3961066A (no)
JP (1) JPS5817190B2 (no)
AT (1) AT335630B (no)
AU (1) AU475932B2 (no)
BE (1) BE813096A (no)
CA (1) CA1040629A (no)
CH (1) CH594628A5 (no)
CS (1) CS183732B2 (no)
DE (1) DE2415124A1 (no)
ES (1) ES424787A1 (no)
FI (1) FI56835C (no)
FR (1) FR2223043B1 (no)
GB (1) GB1460053A (no)
HU (1) HU169133B (no)
NL (1) NL7404411A (no)
NO (1) NO142713C (no)
SE (1) SE413025B (no)
SU (1) SU591141A3 (no)
ZA (1) ZA742013B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205171A (en) * 1976-01-12 1980-05-27 Sterling Drug Inc. Aminomethanobenzazocines and nitromethanobenzazocines
CN111978252A (zh) * 2019-05-21 2020-11-24 复旦大学 手性苯并吗吩烷类衍生物及其制备方法和在药学上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639407A (en) * 1965-05-05 1972-02-01 Geigy Chem Corp Novel 1 2 3 4 5 6-hexahydro-6-phenyl-2 6-methano-3-benzazocines
US3833595A (en) * 1968-12-26 1974-09-03 Sumitomo Chemical Co 2-aroylalkyl benzomorphans
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
US3793332A (en) * 1972-05-22 1974-02-19 Sumitomo Chemical Co 2-cyano alkylbenzomorphan derivatives and salts thereof

Also Published As

Publication number Publication date
CS183732B2 (en) 1978-07-31
ES424787A1 (es) 1976-11-16
DE2415124A1 (de) 1974-10-10
SE413025B (sv) 1980-03-31
AU475932B2 (en) 1976-09-09
AT335630B (de) 1977-03-25
HU169133B (no) 1976-09-28
JPS49124069A (no) 1974-11-27
GB1460053A (en) 1976-12-31
FI56835B (fi) 1979-12-31
CH594628A5 (no) 1978-01-13
FR2223043A1 (no) 1974-10-25
BE813096A (fr) 1974-09-30
FI56835C (fi) 1980-04-10
ZA742013B (en) 1975-03-26
US3961066A (en) 1976-06-01
CA1040629A (en) 1978-10-17
NO142713B (no) 1980-06-23
NO741126L (no) 1974-10-01
SU591141A3 (ru) 1978-01-30
FR2223043B1 (no) 1977-07-01
ATA259274A (de) 1976-07-15
NL7404411A (no) 1974-10-02
JPS5817190B2 (ja) 1983-04-05
AU6735274A (en) 1975-10-09

Similar Documents

Publication Publication Date Title
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO142304C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater
NO143846C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater
NO144455C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive nye piperidinderivater.
SE424324B (sv) Analogiforfarande for framstellning av 1,2-benzisoxazolderivat
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO144743C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye penicillinderivater
NO142865C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler
NO145791C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater
NO143223C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner
NO141648C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 2-oxazolinderivater
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO150882C (no) Analogifremgangsmaate ved fremstilling av nye 1,4-benzoksazin-derivater
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO141161C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive morfinanderivater
NO141160C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3,4-dihydro-2(1h)-isokinolinkarboksamider
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO140858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 2,4-diamino-5-benzyl-pyrimidinderivater
FI55659C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 3-(4-substituerad-piperazin-1-ylkarbonyloxi)-2-(1,8-naftyridin-2-yl)isoindolin-1-oner
NO141441C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
NO144457C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner
NO146497C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-anilino-oxazoliner
NO144039C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk virksomme benzofuranderivater
NO150281C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 3,4,5,6-tetrahydro(1,3)thiazolo(3,4-a)isokinolinderivater